Patent · US Active

DNA2 inhibitors for cancer treatment

US10562856B2 · kind B2 · utility

2Cited by

2References

8Claims

0Family size

Assignees

City of Hope · US
CALIFORNIA INSTITUTE OF TECHNOLOGY · US

Inventors

Binghui Shen · Duarte, US
Judith Campbell · Sierra Madre, US
Li Zheng · Beijing, CN
Hongzhi Li · New York, US
David Horne · Duarte, US
Jun Xie · Singapore, SG
Kenneth Karanja · Maple Grove, US

Key dates

Filing date	Nov 30, 2018
Grant date	Feb 18, 2020
Priority date	—
Expiry date	Nov 30, 2038

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K45/06
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Disclosed herein, inter alia, are compositions and methods for inhibiting DNA2.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.